GC WellBeing Corporation (KOSDAQ:234690)
South Korea · Delayed Price · Currency is KRW 9,680.00
+560.00 (6.14%)
At close: Aug 11, 2026
GC WellBeing Market Cap
GC WellBeing has a market cap or net worth of 173.82 billion as of August 12, 2026. Its market cap has decreased by -2.05% in one year.
Market Cap
173.82B
Enterprise Value
251.96B
Revenue
179.05B
Ranking
n/a
PE Ratio
92.01
Stock Price
9,680.00
ChartMarket Cap Chart
Since October 14, 2019, GC WellBeing's market cap has decreased from 221.90B to 173.82B, a decrease of -21.67%. That is a compound annual growth rate of -3.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 173.82B | 7.17% |
| Dec 30, 2025 | 162.19B | -9.18% |
| Dec 30, 2024 | 178.59B | 23.74% |
| Dec 28, 2023 | 144.33B | -1.22% |
| Dec 29, 2022 | 146.10B | -18.92% |
| Dec 30, 2021 | 180.19B | -27.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cosmax Nbt | 177.39B |
| CellBion | 172.54B |
| Vivozon Pharmaceutical | 169.36B |
| DAE HWA Pharmaceutical | 165.53B |
| Ahn-Gook Pharmaceutical | 146.73B |
| Kyung Dong Pharmaceutical | 135.79B |
| PHARMARESEARCH BIO | 130.86B |
| High Tech Pharm | 120.90B |